Komori
Share Issuance and Disposal7749MEDIKIT CO.,LTD.Electrical Equipment and Precision Instruments

Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock-Based Compensation

Payment for the disposal of 12,700 treasury shares as restricted stock compensation has been completed.

Worth reading
34Immaterial
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
12700
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Disposal of treasury shares as restricted stock compensation

Who receives how much12,700Shares

12,700 treasury shares

Directors of the Company (excluding outside directors)3 / 7,500 shares
The Company's executive officers who do not concurrently serve as directors4 / 2,000 shares
Directors of the Company's subsidiaries4 / 2,000 shares
Executive officers of the Company's subsidiary6 / 1,200 shares

The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.

¥2,787 per share
Total issue value

¥35,394,900

Categories and Number of Persons Covered
Category Directors of the Company (excluding outside directors) / Number of Employees 3 / Number of allocated shares 7,500 shares, Category The Company's executive officers who do not concurrently serve as directors / Number of Employees 4 / Number of allocated shares 2,000 shares, Category Directors of the Company's subsidiaries / Number of Employees 4 / Number of allocated shares 2,000 shares, Category Executive officers of the Company's subsidiary / Number of Employees 6 / Number of allocated shares 1,200 shares
Payment date
24 July 2026
Details of issuance or disposal
ItemDetails
Type of issuance or disposalDisposal of treasury shares as restricted stock compensation
Number of shares to be issued or disposed of12,700 treasury shares
Issue price and disposal price¥2,787 per share
Total issue value¥35,394,900
Payment date24 July 2026
Intended allotteeCategory Directors of the Company (excluding outside directors) / Number of Employees 3 / Number of Shares 7,500 shares, Category The Company's executive officers who do not concurrently serve as directors / Number of Employees 4 / Number of Shares 2,000 shares, Category Directors of the Company's subsidiaries / Number of Employees 4 / Number of Shares 2,000 shares, Category Executive officers of the Company's subsidiary / Number of Employees 6 / Number of Shares 1,200 shares
Categories and Number of Persons CoveredCategory Directors of the Company (excluding outside directors) / Number of Employees 3 / Number of allocated shares 7,500 shares, Category The Company's executive officers who do not concurrently serve as directors / Number of Employees 4 / Number of allocated shares 2,000 shares, Category Directors of the Company's subsidiaries / Number of Employees 4 / Number of allocated shares 2,000 shares, Category Executive officers of the Company's subsidiary / Number of Employees 6 / Number of allocated shares 1,200 shares
Items this document does not state (21)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The payment procedures for the disposal of treasury shares as restricted stock compensation, as resolved at the Board of Directors meeting held on 25 June 2026, have been completed.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock-Based Compensation | MEDIKIT CO.,LTD. (7749) timely disclosure | Komori